健倍苗苗(02161.HK) 公布,预期截至2025年3月31日止年度股东应占综合溢利将较去年同期增加不少于50%。集团指,综合溢利大幅增长,主要归因于精准品牌管理推广活动,成功带动集团核心品牌录得强劲销售表现,尤其是品牌药分部的何济公以及品牌中药分部的保济丸及飞鹰活络油。(ss/a)(港股报价延迟最少十五分钟。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/11/19 | 中期业绩 | 股息:港元 0.0550 |
2024/06/18 | 末期业绩 | 股息:港元 0.0405 |
2023/11/22 | 中期业绩 | 股息:港元 0.0345 |
2023/06/15 | 末期业绩 | 股息:港元 0.0250 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.